# EDGAR Filing Document

**Accession Number:** 0001600004
**File Stem:** 0002000324-25-002412
**Filing Date:** 2025-7
**Character Count:** 49842
**Document Hash:** 45ef0a74f6567e88bceb4d8a2c238160
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002000324-25-002412.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0002000324-25-002412

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250725

**EFFECTIVENESS DATE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** First Light Asset Management, LLC
- **CENTRAL INDEX KEY:** 0001600004

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16064
- **FILM NUMBER:** 251149961

**BUSINESS ADDRESS:**
- **STREET 1:** 3300 EDINBOROUGH WAY
- **STREET 2:** SUITE 201
- **CITY:** EDINA
- **STATE:** MN
- **ZIP:** 55435
- **BUSINESS PHONE:** 952-831-6500

**MAIL ADDRESS:**
- **STREET 1:** 3300 EDINBOROUGH WAY
- **STREET 2:** SUITE 201
- **CITY:** EDINA
- **STATE:** MN
- **ZIP:** 55435

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001600004

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** First Light Asset Management, LLC

**Address:** 3300 Edinborough Way, Edina, MN 55435

**Telephone number:** 952-230-3888

**Name of agent for service:** Client's Agent provides proxy services

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-16064

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                  | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Twist Bioscience Corporation    | 90184D100 | 02/05/2025     | To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         857427 |           328822 | FOR         |                                   857427 | FOR                         |  |
| Twist Bioscience Corporation    | 90184D100 | 02/05/2025     | To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the "EIP") to increase the number of shares of common stock reserved for issuance of awards under the EIP, eliminate the "evergreen" provision and make other amendments.                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         857427 |           328822 | FOR         |                                   857427 | FOR                         |  |
| Twist Bioscience Corporation    | 90184D100 | 02/05/2025     | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter") to increase the number of shares of common stock of the Company authorized thereunder by an additional 100,000,000 shares.                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         857427 |           328822 | FOR         |                                   857427 | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.  | 90400D108 | 05/15/2025     | Approval of the Second Amended and Restated 2023 Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         608456 |                0 | FOR         |                                   608456 | FOR                         |  |
| Paragon 28. Inc.                | 69913P105 | 04/17/2025     | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger.                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         990977 |                0 | FOR         |                                   990977 | FOR                         |  |
| Koru Medical Systems, Inc.      | 759910102 | 05/14/2025     | Approval, on an advisory basis, of the compensation of the Company's executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        4372032 |                0 | FOR         |                                  4372032 | FOR                         |  |
| Vera Therapeutics, Inc.         | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1570885 |                0 | FOR         |                                  1570885 | FOR                         |  |
| Vera Therapeutics, Inc.         | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1570885 |                0 | FOR         |                                  1570885 | FOR                         |  |
| Insmed Incorporated             | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          62522 |                0 | FOR         |                                    62522 | FOR                         |  |
| Insmed Incorporated             | 457669307 | 05/15/2025     | Approval of Amendment No. 2 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          62522 |                0 | FOR         |                                    62522 | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.  | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         608456 |                0 | FOR         |                                   608456 | FOR                         |  |
| Repligen Corporation            | 759916109 | 05/15/2025     | Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         104284 |                0 | FOR         |                                   104284 | FOR                         |  |
| Atricure, Inc.                  | 04963C209 | 05/19/2025     | Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,700,000.                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1286250 |                0 | FOR         |                                  1286250 | FOR                         |  |
| Atricure, Inc.                  | 04963C209 | 05/19/2025     | Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1286250 |                0 | FOR         |                                  1286250 | FOR                         |  |
| Atricure, Inc.                  | 04963C209 | 05/19/2025     | Advisory vote on the frequency of future advisory votes on compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1286250 |                0 | FOR         |                                  1286250 | FOR                         |  |
| Tandem Diabetes Care, Inc.      | 875372203 | 05/21/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         228539 |                0 | FOR         |                                   228539 | FOR                         |  |
| Tandem Diabetes Care, Inc.      | 875372203 | 05/21/2025     | To approve, on a non-binding, advisory basis, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         228539 |                0 | FOR         |                                   228539 | FOR                         |  |
| Senseonics Holdings, Inc.       | 81727U105 | 05/21/2025     | Advisory approval of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        4657505 |                0 | FOR         |                                  4657505 | FOR                         |  |
| Insulet Corporation             | 45784P101 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of certain executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          15496 |                0 | FOR         |                                    15496 | FOR                         |  |
| Insulet Corporation             | 45784P101 | 05/22/2025     | To approve the Insulet Corporation 2025 Stock Option and Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          15496 |                0 | FOR         |                                    15496 | FOR                         |  |
| Neogenomics, Inc.               | 64049M209 | 05/22/2025     | Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        5427180 |                0 | FOR         |                                  5427180 | FOR                         |  |
| Neogenomics, Inc.               | 64049M209 | 05/22/2025     | Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        5427180 |                0 | FOR         |                                  5427180 | FOR                         |  |
| Neogenomics, Inc.               | 64049M209 | 05/22/2025     | Approval of the First Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        5427180 |                0 | FOR         |                                  5427180 | FOR                         |  |
| Transmedics Group, Inc.         | 89377M109 | 05/22/2025     | To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         100893 |                0 | FOR         |                                   100893 | FOR                         |  |
| Establishment Labs Holdings Inc | G31249108 | 05/23/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         326926 |                0 | FOR         |                                   326926 | FOR                         |  |
| iRhythm Technologies, Inc.      | 450056106 | 05/28/2025     | To approve, on a non-binding advisory basis, the named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         311611 |                0 | FOR         |                                   311611 | FOR                         |  |
| Adma Biologics, Inc.            | 000899104 | 06/04/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         304955 |                0 | FOR         |                                   304955 | FOR                         |  |
| Adma Biologics, Inc.            | 000899104 | 06/04/2025     | To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         304955 |                0 | FOR         |                                   304955 | FOR                         |  |
| Xenon Pharmaceuticals Inc       | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         560747 |            42160 | FOR         |                                   560747 | FOR                         |  |
| Oscar Health, Inc.              | 687793109 | 06/04/2025     | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         471975 |                0 | FOR         |                                   471975 | FOR                         |  |
| Evolent Health, Inc.            | 30050B101 | 06/05/2025     | Proposal to approve the compensation of our named executive officers for 2024 on an advisory basis.                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         314446 |                0 | FOR         |                                   314446 | FOR                         |  |
| Evolent Health, Inc.            | 30050B101 | 06/05/2025     | Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         314446 |                0 | FOR         |                                   314446 | FOR                         |  |
| Si-Bone, Inc.                   | 825704109 | 06/05/2025     | Advisory vote to approve executive compensation "Say-on-Pay".                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1553087 |                0 | FOR         |                                  1553087 | FOR                         |  |
| Alignment Healthcare Inc        | 01625V104 | 06/05/2025     | Approve, on an advisory basis, the compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         916455 |                0 | FOR         |                                   916455 | FOR                         |  |
| Radnet, Inc.                    | 74253Q580 | 06/10/2025     | An advisory vote to approve the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          11520 |                0 | FOR         |                                    11520 | FOR                         |  |
| Crinetics Pharmaceuticals Inc.  | 22663K107 | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         821314 |                0 | FOR         |                                   821314 | FOR                         |  |
| Janux Therapeutics, Inc.        | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         225249 |                0 | FOR         |                                   225249 | FOR                         |  |
| Janux Therapeutics, Inc.        | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         225249 |                0 | FOR         |                                   225249 | FOR                         |  |
| Butterfly Network, Inc.         | 124155102 | 06/12/2025     | To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        6806790 |                0 | FOR         |                                  6806790 | FOR                         |  |
| Edgewise Therapeutics Inc       | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1908488 |                0 | FOR         |                                  1908488 | FOR                         |  |
| Edgewise Therapeutics Inc       | 28036F105 | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1908488 |                0 | FOR         |                                  1908488 | FOR                         |  |
| Anaptysbio, Inc.                | 032724106 | 06/17/2025     | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        4111731 |                0 | FOR         |                                  4111731 | FOR                         |  |
| Anaptysbio, Inc.                | 032724106 | 06/17/2025     | To approve an amendment to our 2017 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        4111731 |                0 | FOR         |                                  4111731 | FOR                         |  |
| Anaptysbio, Inc.                | 032724106 | 06/17/2025     | Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        4111731 |                0 | FOR         |                                  4111731 | FOR                         |  |
| Axogen, Inc.                    | 05463X106 | 06/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        4316219 |                0 | FOR         |                                  4316219 | FOR                         |  |
| Axogen, Inc.                    | 05463X106 | 06/18/2025     | To approve the Axogen, Inc. Fourth Amended and Restated 2019 Long-Term Incentive Plan to increase the number of shares authorized for issuance thereunder from 10,500,000 to 13,400,000.                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        4316219 |                0 | FOR         |                                  4316219 | FOR                         |  |
| Axogen, Inc.                    | 05463X106 | 06/18/2025     | To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        4316219 |                0 | FOR         |                                  4316219 | FOR                         |  |
| Guardant Health Inc             | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         182747 |                0 | FOR         |                                   182747 | FOR                         |  |
| Mimedx Group, Inc               | 602496101 | 06/18/2025     | Advisory approval of executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |        3251360 |                0 | FOR         |                                  3251360 | FOR                         |  |
| Mimedx Group, Inc               | 602496101 | 06/18/2025     | Amendment of 2016 Equity and Cash Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        3251360 |                0 | FOR         |                                  3251360 | FOR                         |  |
| Mimedx Group, Inc               | 602496101 | 06/18/2025     | Advisory vote on frequency of advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        3251360 |                0 | FOR         |                                  3251360 | FOR                         |  |
| Centessa Pharmaceuticals PLC    | 152309100 | 06/20/2025     | To receive and approve, on an advisory basis, the Company's U.K. statutory directors' remuneration report for the financial year ended December 31, 2024 (other than the Director's Remuneration Policy which is set on pages A-3 to A-25 of the director's remuneration report), which is set forth as Annex A to the attached proxy statement.                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        4659090 |                0 | FOR         |                                  4659090 | FOR                         |  |
| Centessa Pharmaceuticals PLC    | 152309100 | 06/20/2025     | To receive and approve the Directors' Remuneration Policy as set out on pages A-3 to A-25 of the Company's UK statutory directors' remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the attached proxy statement, which will take effect immediately after the end of the AGM.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        4659090 |                0 | FOR         |                                  4659090 | FOR                         |  |
| Centessa Pharmaceuticals PLC    | 152309100 | 06/20/2025     | To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the UK Companies Act 2006 (the "Companies Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company ("Rights") up to an aggregate nominal amount of $133,184 for a period expiring (unless previously renewed, varied or ...(due to space limits, see proxy material for full proposal).       | SECTION 14A SAY-ON-PAY VOTES |        4659090 |                0 | FOR         |                                  4659090 | FOR                         |  |
| Centessa Pharmaceuticals PLC    | 152309100 | 06/20/2025     | To generally empower, conditional upon resolution 9 above being duly passed and pursuant to section 570 of the Companies Act, the directors of the Company or any duly authorised committee of the directors to allot equity securities (within the meaning of the Companies Act) for cash pursuant to the authority conferred on them by resolution 9 as if section 561 of the Companies Act and any pre-emption provisions in the articles of association of ...(due to space limits, see proxy material for full proposal). | SECTION 14A SAY-ON-PAY VOTES |        4659090 |                0 | FOR         |                                  4659090 | FOR                         |  |
| Structure Therapeutics          | 86366E106 | 06/23/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         119051 |                0 | FOR         |                                   119051 | FOR                         |  |
| Structure Therapeutics          | 86366E106 | 06/23/2025     | TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         119051 |                0 | FOR         |                                   119051 | FOR                         |  |
| Organogenesis Holdings Inc      | 68621F102 | 06/23/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2025 annual meeting of shareholders.                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        2249675 |                0 | FOR         |                                  2249675 | FOR                         |  |
| Organogenesis Holdings Inc      | 68621F102 | 06/23/2025     | Approval of the issuance of, or in excess of, 20% of the Company's outstanding Class A common stock upon the conversion of the Company's Series A Convertible Preferred Stock at less than the "minimum price" under Nasdaq Listing Rule 5635(d), and which may be deemed a "change of control" under Nasdaq Listing Rule 5635(b) or any successor rule, pursuant to the terms of the Certificate of Designations of Series A Convertible Preferred Stock governing the Series A Convertible Preferred Stock.                  | SECTION 14A SAY-ON-PAY VOTES |        2249675 |                0 | FOR         |                                  2249675 | FOR                         |  |
| Rhythm Pharmaceuticals, Inc.    | 76243J105 | 06/24/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          32003 |                0 | FOR         |                                    32003 | FOR                         |  |
| Health Catalyst, Inc.           | 42225T107 | 07/09/2025     | To approve, on an advisory, non-binding basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |       11523422 |                0 | FOR         |                                 11523422 | FOR                         |  |
| Avid Bioservices, Inc.          | 05368M106 | 10/16/2024     | To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement.                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        2154678 |             9271 | FOR         |                                  2154678 | FOR                         |  |
| Avid Bioservices, Inc.          | 05368M106 | 10/16/2024     | To approve an amendment to the Company's 2018 Omnibus Incentive Plan to increase the number of shares reserved thereunder.                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        2154678 |             9271 | FOR         |                                  2154678 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** First Light Asset Management, LLC

**By (Signature):** Kurt Peterson

**By (Printed Signature):** Kurt Peterson

**By (Title):** CCO

**Date:** 07/24/2025